{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:08:33Z","timestamp":1722816513615},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T00:00:00Z","timestamp":1435622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T00:00:00Z","timestamp":1435622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/gt.2015.61","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T14:40:57Z","timestamp":1435675257000},"page":"883-892","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tightly regulated \u2018all-in-one\u2019 lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy"],"prefix":"10.1038","volume":"22","author":[{"given":"N","family":"Lachmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Brennig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hillje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Schermeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Phaltane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Dahlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Gruh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Schiedlmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Baum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"BFgt201561_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/hum.2011.058","volume":"22","author":"B Dropulic","year":"2011","unstructured":"Dropulic B . Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research. Hum Gene Ther 2011; 22: 649\u2013657.","journal-title":"Hum Gene Ther"},{"key":"BFgt201561_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1042\/BJ20120146","volume":"443","author":"T Sakuma","year":"2012","unstructured":"Sakuma T, Barry MA, Ikeda Y . Lentiviral vectors: basic to translational. Biochem J 2012; 443: 603\u2013618.","journal-title":"Biochem J"},{"key":"BFgt201561_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/156652308786848049","volume":"8","author":"A Schambach","year":"2008","unstructured":"Schambach A, Baum C . Clinical application of lentiviral vectors\u2014concepts and practice. Curr Gene Ther 2008; 8: 474\u2013482.","journal-title":"Curr Gene Ther"},{"key":"BFgt201561_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/hum.2012.229","volume":"24","author":"A Schambach","year":"2013","unstructured":"Schambach A, Zychlinski D, Ehrnstroem B, Baum C . Biosafety features of lentiviral vectors. Hum Gene Ther 2013; 24: 132\u2013142.","journal-title":"Hum Gene Ther"},{"key":"BFgt201561_CR5","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-08-0320","volume":"68","author":"MD Milsom","year":"2008","unstructured":"Milsom MD, Jerabek-Willemsen M, Harris CE, Schambach A, Broun E, Bailey J et al. Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells. Cancer Res 2008; 68: 6171\u20136180.","journal-title":"Cancer Res"},{"key":"BFgt201561_CR6","doi-asserted-by":"publisher","first-page":"58ra84","DOI":"10.1126\/scitranslmed.3001522","volume":"2","author":"B Gentner","year":"2010","unstructured":"Gentner B, Visigalli I, Hiramatsu H, Lechman E, Ungari S, Giustacchini A et al. Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy. Sci Transl Med 2010; 2: 58ra84.","journal-title":"Sci Transl Med"},{"key":"BFgt201561_CR7","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","volume":"89","author":"M Gossen","year":"1992","unstructured":"Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547\u20135551.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201561_CR8","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1126\/science.7792603","volume":"268","author":"M Gossen","year":"1995","unstructured":"Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H . Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766\u20131769.","journal-title":"Science"},{"key":"BFgt201561_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/sj.gt.3301889","volume":"10","author":"JK Koponen","year":"2003","unstructured":"Koponen JK, Kankkonen H, Kannasto J, Wirth T, Hillen W, Bujard H et al. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Therapy 2003; 10: 459\u2013466.","journal-title":"Gene Therapy"},{"key":"BFgt201561_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jgm.712","volume":"7","author":"K Pluta","year":"2005","unstructured":"Pluta K, Luce MJ, Bao L, Agha-Mohammadi S, Reiser J . Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J Gene Med 2005; 7: 803\u2013817.","journal-title":"J Gene Med"},{"key":"BFgt201561_CR11","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1634\/stemcells.2007-0248","volume":"25","author":"DS Vieyra","year":"2007","unstructured":"Vieyra DS, Goodell MA . Pluripotentiality and conditional transgene regulation in human embryonic stem cells expressing insulated tetracycline-ON transactivator. Stem Cells 2007; 25: 2559\u20132566.","journal-title":"Stem Cells"},{"key":"BFgt201561_CR12","doi-asserted-by":"publisher","first-page":"e64389","DOI":"10.1371\/journal.pone.0064389","volume":"8","author":"WH Yang","year":"2013","unstructured":"Yang WH, Yang C, Xue YQ, Lu T, Reiser J, Zhao LR et al. Regulated expression of lentivirus-mediated GDNF in human bone marrow-derived mesenchymal stem cells and its neuroprotection on dopaminergic cells in vitro. PLoS One 2013; 8: e64389.","journal-title":"PLoS One"},{"key":"BFgt201561_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ymthe.2005.09.012","volume":"13","author":"I Barde","year":"2006","unstructured":"Barde I, Zanta-Boussif MA, Paisant S, Leboeuf M, Rameau P, Delenda C et al. Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol Ther 2006; 13: 382\u2013390.","journal-title":"Mol Ther"},{"key":"BFgt201561_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/gt.2009.109","volume":"17","author":"M Centlivre","year":"2010","unstructured":"Centlivre M, Zhou X, Pouw SM, Weijer K, Kleibeuker W, Das AT et al. Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo. Gene Ther 2010; 17: 14\u201325.","journal-title":"Gene Ther"},{"key":"BFgt201561_CR15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/hum.2010.179","volume":"22","author":"M Giry-Laterriere","year":"2011","unstructured":"Giry-Laterriere M, Cherpin O, Kim YS, Jensen J, Salmon P . Polyswitch lentivectors: 'all-in-one' lentiviral vectors for drug-inducible gene expression, live selection, and recombination cloning. Hum Gene Ther 2011; 22: 1255\u20131267.","journal-title":"Hum Gene Ther"},{"key":"BFgt201561_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/bab.1239","volume":"62","author":"Y Huang","year":"2014","unstructured":"Huang Y, Zhen R, Jiang M, Yang J, Yang Y, Huang Z et al. Development of all-in-one multicistronic Tet-On lentiviral vectors for inducible co-expression of two transgenes. Biotechnol Appl Biochem 2014; 62: 48\u201354.","journal-title":"Biotechnol Appl Biochem"},{"key":"BFgt201561_CR17","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1093\/nar\/gni062","volume":"33","author":"D Markusic","year":"2005","unstructured":"Markusic D, Oude-Elferink R, Das AT, Berkhout B, Seppen J . Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res 2005; 33: e63.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201561_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nbt.1720","volume":"29","author":"J Zuber","year":"2011","unstructured":"Zuber J, McJunkin K, Fellmann C, Dow LE, Taylor MJ, Hannon GJ et al. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat Biotechnol 2011; 29: 79\u201383.","journal-title":"Nat Biotechnol"},{"key":"BFgt201561_CR19","doi-asserted-by":"publisher","first-page":"e41007","DOI":"10.1371\/journal.pone.0041007","volume":"7","author":"T Yamaguchi","year":"2012","unstructured":"Yamaguchi T, Hamanaka S, Kamiya A, Okabe M, Kawarai M, Wakiyama Y et al. Development of an all-in-one inducible lentiviral vector for gene specific analysis of reprogramming. PLoS One 2012; 7: e41007.","journal-title":"PLoS One"},{"key":"BFgt201561_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/hum.2008.018","volume":"20","author":"X Tian","year":"2009","unstructured":"Tian X, Wang G, Xu Y, Wang P, Chen S, Yang H et al. An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector. Hum Gene Ther 2009; 20: 113\u2013123.","journal-title":"Hum Gene Ther"},{"key":"BFgt201561_CR21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/jvi.70.1.62-67.1996","volume":"70","author":"W Paulus","year":"1996","unstructured":"Paulus W, Baur I, Boyce FM, Breakefield XO, Reeves SA . Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70: 62\u201367.","journal-title":"J Virol"},{"key":"BFgt201561_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ymthe.2004.11.017","volume":"11","author":"E Vigna","year":"2005","unstructured":"Vigna E, Amendola M, Benedicenti F, Simmons AD, Follenzi A, Naldini L . Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector. Mol Ther 2005; 11: 763\u2013775.","journal-title":"Mol Ther"},{"key":"BFgt201561_CR23","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.1073\/pnas.130192197","volume":"97","author":"S Urlinger","year":"2000","unstructured":"Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W . Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 2000; 97: 7963\u20137968.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201561_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/jgm.566","volume":"6","author":"S Agha-Mohammadi","year":"2004","unstructured":"Agha-Mohammadi S, O'Malley M, Etemad A, Wang Z, Xiao X, Lotze MT . Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med 2004; 6: 817\u2013828.","journal-title":"J Gene Med"},{"key":"BFgt201561_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/hum.2010.099","volume":"22","author":"N Heinz","year":"2011","unstructured":"Heinz N, Schambach A, Galla M, Maetzig T, Baum C, Loew R et al. Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic range. Hum Gene Ther 2011; 22: 166\u2013176.","journal-title":"Hum Gene Ther"},{"key":"BFgt201561_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1472-6750-10-81","volume":"10","author":"R Loew","year":"2010","unstructured":"Loew R, Heinz N, Hampf M, Bujard H, Gossen M . Improved Tet-responsive promoters with minimized background expression. BMC Biotechnol 2010; 10: 81.","journal-title":"BMC Biotechnol"},{"key":"BFgt201561_CR27","first-page":"133ra57","volume":"4","author":"JE Adair","year":"2012","unstructured":"Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL et al. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci Transl Med 2012; 4: 133ra57.","journal-title":"Sci Transl Med"},{"key":"BFgt201561_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000072458","volume":"110","author":"M Flasshove","year":"2003","unstructured":"Flasshove M, Moritz T, Bardenheuer W, Seeber S . Hematoprotection by transfer of drug-resistance genes. Acta Haematol 2003; 110: 93\u2013106.","journal-title":"Acta Haematol"},{"key":"BFgt201561_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1593\/neo.121954","volume":"15","author":"N Lachmann","year":"2013","unstructured":"Lachmann N, Brennig S, Phaltane R, Flasshove M, Dilloo D, Moritz T . Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy. Neoplasia 2013; 15: 239\u2013248.","journal-title":"Neoplasia"},{"key":"BFgt201561_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/14653240152584640","volume":"3","author":"T Moritz","year":"2001","unstructured":"Moritz T, Williams DA . Marrow protection\u2014transduction of hematopoietic cells with drug resistance genes. Cytotherapy 2001; 3: 67\u201384.","journal-title":"Cytotherapy"},{"key":"BFgt201561_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood-2004-08-3169","volume":"105","author":"T Neff","year":"2005","unstructured":"Neff T, Beard BC, Peterson LJ, Anandakumar P, Thompson J, Kiem HP . Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood 2005; 105: 997\u20131002.","journal-title":"Blood"},{"key":"BFgt201561_CR32","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0145-2126(99)00128-9","volume":"23","author":"M Flasshove","year":"1999","unstructured":"Flasshove M, Frings W, Schroder JK, Moritz T, Schutte J, Seeber S . Transfer of the cytidine deaminase cDNA into hematopoietic cells. Leuk Res 1999; 23: 1047\u20131053.","journal-title":"Leuk Res"},{"key":"BFgt201561_CR33","first-page":"1340","volume":"24","author":"T Neff","year":"1996","unstructured":"Neff T, Blau CA . Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine. Exp Hematol 1996; 24: 1340\u20131346.","journal-title":"Exp Hematol"},{"key":"BFgt201561_CR34","first-page":"331","volume":"3","author":"RL Momparler","year":"1996","unstructured":"Momparler RL, Eliopoulos N, Bovenzi V, Letourneau S, Greenbaum M, Cournoyer D . Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. Cancer Gene Ther 1996; 3: 331\u2013338.","journal-title":"Cancer Gene Ther"},{"key":"BFgt201561_CR35","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/sj.leu.2403977","volume":"19","author":"W Bardenheuer","year":"2005","unstructured":"Bardenheuer W, Lehmberg K, Rattmann I, Brueckner A, Schneider A, Sorg UR et al. Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells. Leukemia 2005; 19: 2281\u20132288.","journal-title":"Leukemia"},{"key":"BFgt201561_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3109\/14653249.2011.646043","volume":"14","author":"S Brennig","year":"2012","unstructured":"Brennig S, Rattmann I, Lachmann N, Schambach A, Williams DA, Moritz T . In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application. Cytotherapy 2012; 14: 451\u2013460.","journal-title":"Cytotherapy"},{"key":"BFgt201561_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/gt.2012.40","volume":"20","author":"N Lachmann","year":"2013","unstructured":"Lachmann N, Brennig S, Pfaff N, Schermeier H, Dahlmann J, Phaltane R et al. Efficient in vivo regulation of cytidine deaminaseexpression in the haematopoietic system using a doxycycline-inducible lentiviral vector system. Gene Therapy 2013; 20: 298\u2013307.","journal-title":"Gene Therapy"},{"key":"BFgt201561_CR38","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1182\/blood-2006-03-011734","volume":"108","author":"I Rattmann","year":"2006","unstructured":"Rattmann I, Kleff V, Sorg UR, Bardenheuer W, Brueckner A, Hilger RA et al. Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model. Blood 2006; 108: 2965\u20132971.","journal-title":"Blood"},{"key":"BFgt201561_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"H Mizuguchi","year":"2000","unstructured":"Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T . IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 2000; 1: 376\u2013382.","journal-title":"Mol Ther"},{"key":"BFgt201561_CR40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/leu.2012.355","volume":"27","author":"OS Kustikova","year":"2013","unstructured":"Kustikova OS, Schwarzer A, Stahlhut M, Brugman MH, Neumann T, Yang M et al. Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells. Leukemia 2013; 27: 1127\u20131138.","journal-title":"Leukemia"},{"key":"BFgt201561_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/eji.201343591","volume":"44","author":"S Reuss","year":"2014","unstructured":"Reuss S, Sebestyen Z, Heinz N, Loew R, Baum C, Debets R et al. TCR-engineered T cells: a model of inducible TCR expression to dissect the interrelationship between two TCRs. Eur J Immunol 2014; 44: 265\u2013274.","journal-title":"Eur J Immunol"},{"key":"BFgt201561_CR42","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1634\/stemcells.2006-0128","volume":"25","author":"BY Zhou","year":"2007","unstructured":"Zhou BY, Ye Z, Chen G, Gao ZP, Zhang YA, Cheng L . Inducible and reversible transgene expression in human stem cells after efficient and stable gene transfer. Stem Cells 2007; 25: 779\u2013789.","journal-title":"Stem Cells"},{"key":"BFgt201561_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6750-13-5","volume":"13","author":"N Heinz","year":"2013","unstructured":"Heinz N, Hennig K, Loew R . Graded or threshold response of the tet-controlled gene expression: all depends on the concentration of the transactivator. BMC Biotechnol 2013; 13: 5.","journal-title":"BMC Biotechnol"},{"key":"BFgt201561_CR44","doi-asserted-by":"publisher","first-page":"e10611","DOI":"10.1371\/journal.pone.0010611","volume":"5","author":"JY Qin","year":"2010","unstructured":"Qin JY, Zhang L, Clift KL, Hulur I, Xiang AP, Ren BZ et al. Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS One 2010; 5: e10611.","journal-title":"PLoS One"},{"key":"BFgt201561_CR45","doi-asserted-by":"publisher","first-page":"e23734","DOI":"10.1371\/journal.pone.0023734","volume":"6","author":"K Benabdellah","year":"2011","unstructured":"Benabdellah K, Cobo M, Munoz P, Toscano MG, Martin F . Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines. PLoS One 2011; 6: e23734.","journal-title":"PLoS One"},{"key":"BFgt201561_CR46","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1006\/mthe.2000.0083","volume":"1","author":"T Kafri","year":"2000","unstructured":"Kafri T, van Praag H, Gage FH, Verma IM . Lentiviral vectors: regulated gene expression. Mol Ther 2000; 1: 516\u2013521.","journal-title":"Mol Ther"},{"key":"BFgt201561_CR47","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/mt.2009.179","volume":"17","author":"U Modlich","year":"2009","unstructured":"Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009; 17: 1919\u20131928.","journal-title":"Mol Ther"},{"key":"BFgt201561_CR48","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nbt1216","volume":"24","author":"E Montini","year":"2006","unstructured":"Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 2006; 24: 687\u2013696.","journal-title":"Nat Biotechnol"},{"key":"BFgt201561_CR49","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/mt.2014.3","volume":"22","author":"D Cesana","year":"2014","unstructured":"Cesana D, Ranzani M, Volpin M, Bartholomae C, Duros C, Artus A et al. Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo. Mol Ther 2014; 22: 774\u2013785.","journal-title":"Mol Ther"},{"key":"BFgt201561_CR50","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/mt.2008.5","volume":"16","author":"D Zychlinski","year":"2008","unstructured":"Zychlinski D, Schambach A, Modlich U, Maetzig T, Meyer J, Grassman E et al. Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol Ther 2008; 16: 718\u2013725.","journal-title":"Mol Ther"},{"key":"BFgt201561_CR51","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1089\/10430340260201707","volume":"13","author":"M Latta-Mahieu","year":"2002","unstructured":"Latta-Mahieu M, Rolland M, Caillet C, Wang M, Kennel P, Mahfouz I et al. Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression. Hum Gene Ther 2002; 13: 1611\u20131620.","journal-title":"Hum Gene Ther"},{"key":"BFgt201561_CR52","doi-asserted-by":"publisher","first-page":"e9974","DOI":"10.1371\/journal.pone.0009974","volume":"5","author":"DM Markusic","year":"2010","unstructured":"Markusic DM, de Waart DR, Seppen J . Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in rats. PLoS One 2010; 5: e9974.","journal-title":"PLoS One"},{"key":"BFgt201561_CR53","doi-asserted-by":"publisher","first-page":"11605","DOI":"10.1128\/JVI.76.22.11605-11611.2002","volume":"76","author":"D Favre","year":"2002","unstructured":"Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D et al. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol 2002; 76: 11605\u201311611.","journal-title":"J Virol"},{"key":"BFgt201561_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJM199501193320303","volume":"332","author":"CL Mackall","year":"1995","unstructured":"Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143\u2013149.","journal-title":"N Engl J Med"},{"key":"BFgt201561_CR55","doi-asserted-by":"crossref","unstructured":"Hoyng SA, Gnavi S, de Winter F, Eggers R, Ozawa T, Zaldumbide A et al. Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve. Gene Therapy 21: 549\u2013557.","DOI":"10.1038\/gt.2014.22"},{"key":"BFgt201561_CR56","doi-asserted-by":"crossref","unstructured":"Seggewiss R, Einsele H . Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 115: 3861\u20133868.","DOI":"10.1182\/blood-2009-12-234096"},{"key":"BFgt201561_CR57","doi-asserted-by":"crossref","unstructured":"Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF et al. Differentiation of type 1T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway. Blood 116: 935\u2013944.","DOI":"10.1182\/blood-2009-07-234872"},{"key":"BFgt201561_CR58","doi-asserted-by":"crossref","unstructured":"Gordon JR, Ma Y, Churchman L, Gordon SA, Dawicki W . Regulatory dendritic cells for immunotherapy in immunologic diseases. Front Immunol 5: 7.","DOI":"10.3389\/fimmu.2014.00007"},{"key":"BFgt201561_CR59","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.gt.3302698","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Bohne J, Baum C, Hermann FG, Egerer L, von Laer D et al. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Therapy 2006; 13: 641\u2013645.","journal-title":"Gene Therapy"},{"key":"BFgt201561_CR60","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/gt.2011.148","volume":"19","author":"N Lachmann","year":"2012","unstructured":"Lachmann N, Jagielska J, Heckl D, Brennig S, Pfaff N, Maetzig T et al. MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy. Gene Therapy 2012; 19: 915\u2013924.","journal-title":"Gene Therapy"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201561","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:36:31Z","timestamp":1648560991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFgt201561"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.61","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]},"assertion":[{"value":"11 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}